CNXU
NASDAQ HealthcareConexeu Sciences Inc. - Common Stock
Biotechnology
Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis. The company's solutions are supported by preclinical and peer-reviewed data and are positioned as alternatives to conventional fillers or implants, with products currently investigational and pending regulatory clearance for certain applications. The company serves clients in the beauty, aesthetics, regenerative medicine, and medical sectors, including clinicians and professionals involved in facial rejuvenation, body contouring, wound care, and tissue repair. The company was founded in 2022 and is based in Reno, Nevada.
๐ Market Data
| Price | $16.84 |
|---|---|
| Volume | 287,648 |
| 52-Week High | $17.50 |
| 52-Week Low | $10.87 |
| Price / Book | 48.95 |
๐ฏ Investment Strategy Scores
CNXU scores across each investment strategy. Higher is better for that strategy's goals.
๐ Learn More
Indicators on this page
Educational articles
Find CNXU in your text
Paste any article, transcript, or post โ the tool will extract CNXU and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-06-02.